Arbutus Biopharma Corp Annual Shareholders Meeting Transcript
Hello, and welcome to the Arbutus Biopharma Corporation Annual General and Special Meeting of Shareholders. Please note that today's meeting is being recorded.
It is now my pleasure to turn today's meeting over to Mr. Bill Collier. Sir, the floor is yours.
Thank you, and good morning, and welcome to Arbutus Biopharma Corporation's 2021 Annual General and Special Meeting of Shareholders. I'm Bill Collier, President and CEO of Arbutus, and I'll be presiding over the meeting today. We're pleased to host today's meeting through this virtual meeting platform in order to ensure the health and welfare of our shareholders, directors and management in light of the COVID-19 pandemic.
At this time, the meeting is called to order. I would first like to introduce Elizabeth Howard, Arbutus' Executive Vice President and General Counsel, Chief Compliance Officer and Corporate Secretary. Dr. Howard will be serving as Secretary of this meeting. We're also joined today by Ryan
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |